Biomarker profiles in late‐life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71739 ↗Kurz gefasst
Scoping Review in der Zeitschrift Alzheimer's & Dementia, online erschienen am 21.10.2026. Verfasst von Yiqi Zhu und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Depression. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute of Health (NIH) and National Institute on Aging (NIH/NIA).
Themen: Depression, Demenz
Abstract (Originalsprache)
Depression and Alzheimer's disease (AD) frequently overlap clinically, and depressive symptoms may signal major depressive disorder, a risk factor for AD, or an early manifestation of neurodegeneration. This scoping review mapped biomarker evidence differentiating depression and AD within and beyond the amyloid/tau/neurodegeneration (A/T/N) framework. Following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews guidelines, MEDLINE, Embase, and Scopus were searched for studies published between 2010 and 2025 examining biomarkers in depression and AD. Eligible studies included clinical diagnoses of AD and/or depression and reported biomarker measures. Forty‐eight studies met inclusion criteria. Amyloid biomarkers were most consistently associated with clinically diagnosed AD, whereas findings for other biomarkers were more heterogeneous. Neurodegeneration markers, including hippocampal atrophy, were commonly associated with AD, while vascular abnormalities and altered functional connectivity were more frequently linked to depressive symptoms. Overall, AD and depression demonstrated partially distinct but overlapping biomarker profiles, highlighting the need for longitudinal studies using scalable biomarkers to clarify causal and temporal relationships.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
- School of Social Work, Adelphi University, Garden City, New York, USA.
- School of Social Work, St. Louis University, St. Louis, Missouri, USA.
- School of Public Health, Washington University in St. Louis, St. Louis, Missouri, USA.
- University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
- Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Ganesh M Babulal
Förderung
- NIA NIH HHS
- National Institute of Health (NIH) and National Institute on Aging (NIH/NIA)
Zitieren
APA
Zhu, Y., Damera, N., Singh, R. K., Bekena, S., Kelble, L., McGuire, K., Hu, Y., Mersiehazen, E., Vijay, G., Nazif, A., Kolady, R., Xiang, L., Liu, X., Flores, S., Dombrowski, K., Pal, S., Hardi, A., Taylor, K., Trani, J. F., …, & Babulal, G. M. (2026). Biomarker profiles in late‐life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71739
Vancouver
Zhu Y, Damera N, Singh RK, Bekena S, Kelble L, McGuire K, et al. Biomarker profiles in late‐life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71739
BibTeX
@article{Zhu2026,
author = {Zhu, Yiqi and Damera, Nikitha and Singh, Ramkrishna K and Bekena, Semere and Kelble, Laura and McGuire, Katherine and Hu, Yikun and Mersiehazen, Eden and Vijay, Gagan and Nazif, Arya and Kolady, Ramana and Xiang, Liwei and Liu, Xian and Flores, Shaney and Dombrowski, Kaitlyn and Pal, Subrata and Hardi, Angela and Taylor, Kaylin and Trani, Jean-Francois and Ances, Beau M and Lenze, Eric J and Vemuri, Prashanthi and Jack, Clifford R and Petersen, Ronald C and Babulal, Ganesh M},
title = {Biomarker profiles in late‐life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71739}
}
EUVIMED